Whitcomb Brian W, Pradhan Elizabeth Kimbrough, Pittas Anastassios G, Roghmann Mary-Claire, Perencevich Eli N
Department of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA.
Crit Care Med. 2005 Dec;33(12):2772-7. doi: 10.1097/01.ccm.0000189741.44071.25.
Hyperglycemia in intensive care unit patients has been associated with an increased mortality rate, and institutions have already begun tight glucose control programs based on a limited number of clinical trials in restricted populations. This study aimed to assess the generalizability of the association between hyperglycemia and in-hospital mortality in different intensive care unit types adjusting for illness severity and diabetic history.
Retrospective cohort study.
The medical, cardiothoracic surgery, cardiac, general surgical, and neurosurgical intensive care units of the University of Maryland Medical Center.
Patients admitted between July 1996 and January 1998 with length of stay > or = 24 hrs (n = 2713).
On intensive care unit admission, blood glucose and other physiologic variables were evaluated. Regular measurements were taken for calculation of Acute Physiology and Chronic Health Evaluation III scoring. Patients were followed through hospital discharge. Admission blood glucose was used to classify patients as hyperglycemic (> 200 mg/dL) or normoglycemic (60-200 mg/dL). The contribution of hyperglycemia to in-hospital mortality stratified by intensive care unit type and diabetes history while controlling for illness severity was estimated by logistic regression.
The adjusted odds ratios for death comparing all patients with hyperglycemia to those without were 0.81 (95% confidence interval, 0.37, 1.77) and 1.76 (95% confidence interval, 1.23, 2.53) for those with and without diabetic history, respectively. Higher mortality was seen in hyperglycemic patients without diabetic history in the cardiothoracic, (adjusted odds ratio, 2.84 [1.21, 6.63]), cardiac (adjusted odds ratio, 2.64 [1.14, 6.10]), and neurosurgical units (adjusted odds ratio, 2.96 [1.51, 5.77]) but not the medical or surgical intensive care units or in patients with diabetic history.
The association between hyperglycemia on intensive care unit admission and in-hospital mortality was not uniform in the study population; hyperglycemia was an independent risk factor only in patients without diabetic history in the cardiac, cardiothoracic, and neurosurgical intensive care units.
重症监护病房患者的高血糖与死亡率增加相关,一些机构已基于有限数量的针对特定人群的临床试验开展了严格的血糖控制项目。本研究旨在评估在不同类型的重症监护病房中,校正疾病严重程度和糖尿病史后,高血糖与住院死亡率之间关联的普遍性。
回顾性队列研究。
马里兰大学医学中心的内科、心胸外科、心脏科、普通外科和神经外科重症监护病房。
1996年7月至1998年1月期间入院且住院时间≥24小时的患者(n = 2713)。
在重症监护病房入院时,评估血糖及其他生理变量。定期测量以计算急性生理学与慢性健康状况评价III评分。对患者进行随访直至出院。入院血糖用于将患者分类为高血糖(>200 mg/dL)或血糖正常(60 - 200 mg/dL)。通过逻辑回归估计在控制疾病严重程度的情况下,按重症监护病房类型和糖尿病史分层的高血糖对住院死亡率的影响。
在有糖尿病史和无糖尿病史的患者中,将所有高血糖患者与无高血糖患者相比,校正后的死亡比值比分别为0.81(95%置信区间,0.37,1.77)和1.76(95%置信区间,1.23,2.53)。在心胸外科(校正后的比值比,2.84 [1.21, 6.63])、心脏科(校正后的比值比,2.64 [1.14, 6.10])和神经外科病房(校正后的比值比,2.96 [1.51, 5.77])中,无糖尿病史的高血糖患者死亡率较高,但在内科或外科重症监护病房以及有糖尿病史的患者中并非如此。
在研究人群中,重症监护病房入院时的高血糖与住院死亡率之间的关联并不一致;高血糖仅在心脏科、心胸外科和神经外科重症监护病房中无糖尿病史的患者中是独立的危险因素。